Valle D, Goodman S I, Harris S C, Phang J M
J Clin Invest. 1979 Nov;64(5):1365-70. doi: 10.1172/JCI109593.
The initial step in the degradation pathways of proline and hydroxyproline is catalyzed by proline oxidase and hydroxyproline oxidase, yielding delta 1-pyrroline-5-carboxylate and delta 1-pyrroline-3-hydroxy-5-carboxylate, respectively. The second step is the oxidation of delta 1-pyrroline-5-carboxylate to glutamate and delta 1-pyrroline-3-hydroxy-5-carboxylate to gamma-hydroxy-glutamate. To determine if this second step in the degradation of proline and hydroxyproline is catalyzed by a common or by separate enzyme(s), we developed a radioisotopic assay for delta 1-pyrroline-3-hydroxy-5-carboxylate dehydrogenase activity. We then compared delta1-pyrroline-3-hydroxy-5-carboxylate dehydrogenase activity with that of delta 1-pyrroline-5-carboxylate dehydrogenase in fibroblasts and leukocytes from type II hyperprolinemia patients, heterozygotes, and controls. We found that cells from type II hyperprolinemia patients were deficient in both dehydrogenase activities. Furthermore, these activities were highly correlated over the range found in the normals, heterozygotes, and patients. We conclude from these data that a common delta 1-pyrroline-5-carboxylate dehydrogenase catalyzes the oxidation of both delta 1-pyrroline-5-carboxylate and delta 1-pyrroline-3-hydroxy-5-carboxylate, and that this activity is deficient in type II hyperprolinemia.
脯氨酸和羟脯氨酸降解途径的第一步分别由脯氨酸氧化酶和羟脯氨酸氧化酶催化,分别生成Δ1-吡咯啉-5-羧酸和Δ1-吡咯啉-3-羟基-5-羧酸。第二步是将Δ1-吡咯啉-5-羧酸氧化为谷氨酸,将Δ1-吡咯啉-3-羟基-5-羧酸氧化为γ-羟基谷氨酸。为了确定脯氨酸和羟脯氨酸降解的第二步是由一种共同的酶还是由单独的酶催化,我们开发了一种用于检测Δ1-吡咯啉-3-羟基-5-羧酸脱氢酶活性的放射性同位素测定法。然后,我们比较了II型高脯氨酸血症患者、杂合子和对照组的成纤维细胞和白细胞中Δ1-吡咯啉-3-羟基-5-羧酸脱氢酶活性与Δ1-吡咯啉-5-羧酸脱氢酶活性。我们发现,II型高脯氨酸血症患者的细胞中这两种脱氢酶活性均缺乏。此外,在正常、杂合子和患者中发现的活性范围内,这些活性高度相关。我们从这些数据得出结论,一种共同的Δ1-吡咯啉-5-羧酸脱氢酶催化Δ1-吡咯啉-5-羧酸和Δ1-吡咯啉-3-羟基-5-羧酸的氧化,并且这种活性在II型高脯氨酸血症中缺乏。